Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.35 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.32 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.32 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL699213 | 0.77 | ALDH1A1 (0.42) | ALDH1A1TAS1R3TAS1R1CHRNB2CHRNB4 | |
| SCHEMBL11517329 | 0.74 | ALDH1A1 (0.48) | ALDH1A1TAS1R3TAS1R1CHRNB2CHRNB4 | |
| SCHEMBL716407 | 0.74 | ALDH1A1 (0.48) | ALDH1A1TAS1R3TAS1R1CHRNB2CHRNB4 | |
| SCHEMBL1270717 | 0.72 | ALDH1A1 (0.38) | ALDH1A1TAS1R3TAS1R1CHRNB2CHRNB4 | |
| SCHEMBL3671591 | 0.72 | ALDH1A1 (0.46) | ALDH1A1TAS1R3TAS1R1CHRNB2CHRNB4 | |
| SCHEMBL2467595 | 0.72 | ALDH1A1 (0.46) | ALDH1A1TAS1R3TAS1R1CHRNB2CHRNB4 | |
| SCHEMBL220825 | 0.72 | ALDH1A1 (0.46) | ALDH1A1TAS1R3TAS1R1CHRNB2CHRNB4 | |
| SCHEMBL28338609 | 0.71 | ALDH1A1 (0.41) | ALDH1A1TAS1R3TAS1R1CHRNB2CHRNB4 | |
| SCHEMBL6281654 | 0.71 | ESR1 (0.57) | ALDH1A1TAS1R3TAS1R1HDAC8TSHR | |
| SCHEMBL5024850 | 0.71 | TAS1R3 (0.46) | ALDH1A1TAS1R3TAS1R1CHRNB2CHRNB4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1383470-B1 | HAIR TREATMENT COMPOSITIONS | UNILEVER PLC (GB) | 2009-06-17 | — | — | EP | disclosed |
| EP-1383469-B1 | HAIR TREATMENT COMPOSITIONS | UNILEVER PLC (GB) | 2006-02-15 | — | — | EP | disclosed |
| EP-1383860-B1 | FABRIC CARE COMPOSITIONS | UNILEVER PLC (GB) | 2005-10-12 | — | — | EP | disclosed |
| US-6767883-B2 | Fabric care compositions | UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC. | 2004-07-27 | — | — | US | disclosed |
| US-6696050-B2 | COATED PARTICLES COMPRISING (A) A SOLID CORE HAVING A D3, 2 AVERAGE PARTICLE SIZE IN THE RANGE FROM 10 TO 700 NM, AND (B) A COATING POLYMER COVALENTLY BONDED TO THE SOLID CORE; E.G., SOLID SILICA CORES AND POLYSTYRENE COATING POLYMER | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2004-02-24 | — | — | US | disclosed |
| US-6696051-B2 | CONTAINING CORE PARTICLES HAVING A D3,2 AVERAGE PARTICLE SIZE OF 10-700 NM, AND COATED WITH COVALENTLY BONDED SILICONE POLYMER | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2004-02-24 | — | — | US | disclosed |
| EP-1383468-A2 | HAIR TREATMENT COMPOSITIONS | UNILEVER PLC (GB) | 2004-01-28 | — | — | EP | disclosed |
| US-20030095943-A1 | Hair treatment compositions | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2003-05-22 | — | — | US | disclosed |
| US-20030012757-A1 | Hair treatment compositions | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2003-01-16 | — | — | US | disclosed |
| US-20020192367-A1 | Fabric care compositions | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2002-12-19 | — | — | US | disclosed |
| WO-2002087522-A2 | HAIR TREATMENT COMPOSITIONS | UNILEVER PLC (GB) | 2002-11-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030095943-A1 | Hair treatment compositions | SPTLC3, HACD3, C18orf63 | ALDH1A1 379/4885TAS1R3 354/4885TAS1R1 1402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.